Drug Profile
Alnidofibatide
Alternative Names: Klerval™; RPR 109891Latest Information Update: 26 Nov 1999
Price :
$50
*
At a glance
- Originator Aventis
- Class Antiplatelets
- Mechanism of Action GPIIb-IIIa antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial infarction